Amoeba SA
Amoéba S.A. develops biological products and services for the treatment of microbiological risk in the sectors of water, health, and plant protection in France. The company has developed technology to treat water, surfaces, and chronic wounds that uses the natural biocidal capacity of the living amoeba Willaertia magna C2c Maky; and agriculture biocontrol technology for the treatment of phytopath… Read more
Amoeba SA (ALMIB) - Total Liabilities
Latest total liabilities as of June 2025: €20.64 Million EUR
Based on the latest financial reports, Amoeba SA (ALMIB) has total liabilities worth €20.64 Million EUR as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Amoeba SA - Total Liabilities Trend (2011–2024)
This chart illustrates how Amoeba SA's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Amoeba SA Competitors by Total Liabilities
The table below lists competitors of Amoeba SA ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Aminologics Co.Ltd
KQ:074430
|
Korea | ₩26.95 Billion |
|
We & Win Development Co Ltd
TW:2537
|
Taiwan | NT$14.18 Billion |
|
Noroo Paint
KO:090350
|
Korea | ₩280.30 Billion |
|
Columbus A/S
CO:COLUM
|
Denmark | Dkr540.64 Million |
|
DAM CAPITAL ADVISORS LTD
NSE:DAMCAPITAL
|
India | ₹1.73 Billion |
|
Skyline Bankshares Inc.
OTCQX:SLBK
|
USA | $1.20 Billion |
Liability Composition Analysis (2011–2024)
This chart breaks down Amoeba SA's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.28 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.45 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 3.24 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Amoeba SA's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Amoeba SA (2011–2024)
The table below shows the annual total liabilities of Amoeba SA from 2011 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | €16.06 Million | +56.99% |
| 2023-12-31 | €10.23 Million | +141.99% |
| 2022-12-31 | €4.23 Million | -70.44% |
| 2021-12-31 | €14.30 Million | +29.28% |
| 2020-12-31 | €11.06 Million | +15.09% |
| 2019-12-31 | €9.61 Million | +112841.62% |
| 2018-12-31 | €8.51K | -6.05% |
| 2017-12-31 | €9.06K | +93.31% |
| 2016-12-31 | €4.69K | +32.52% |
| 2015-12-31 | €3.54K | -99.87% |
| 2014-12-31 | €2.75 Million | +52.76% |
| 2013-12-31 | €1.80 Million | +133.74% |
| 2012-12-31 | €770.75K | +16.57% |
| 2011-12-31 | €661.17K | -- |